Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins

Journal of Gastrointestinal Cancer

Volumn 43, Issue 1, 2012, Pages 70-76

  Rwigema, Jean Claude M ^a   Heron, Dwight E ^a   Parikh, Simul D ^a   Zeh III, Herbert J ^a   Moser, James A ^a   Bahary, Nathan ^b   Ashby, Karlotta ^a   Burton, Steven A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Adjuvant radiotherapy; Chemoradiotherapy; Chemotherapy; Gemcitabine; Pancreatic cancer; Stereotactic body radiotherapy

Indexed keywords

CAPECITABINE; ERLOTINIB; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN; PACLITAXEL; VANDETANIB;

ADIPOSE TISSUE; ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; CYBERKNIFE; DIARRHEA; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PAIN; PANCREAS ADENOCARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INDUCED EMESIS; RADIATION SICKNESS; RECURRENT DISEASE; RETROPERITONEUM; ROBOTICS; STEREOTACTIC BODY RADIATION THERAPY; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIOSURGERY;

EID: 84857798578     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-010-9203-7     Document Type: Conference Paper

References (34)

1. American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; 2009.
2. D Li K Xie R Wolff, et al. 2004 Pancreatic cancer Lancet 363 1049 1057 15051286 10.1016/S0140-6736(04)15841-8 1:CAS:528:DC%2BD2cXisFOmsLY%3D (Pubitemid 38410779)
3. JL Cameron TS Riall J Coleman KA Belcher 2006 One thousand consecutive pancreaticoduodenectomies Ann Surg 244 1 10 5 16794383 10.1097/01.sla. 0000217673.04165.ea
4. A Richter M Niedergethmann JW Sturm D Lorenz S Post M Trede 2003 Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience World J Surg 27 3 324 9 12607060 10.1007/s00268-002-6659-z (Pubitemid 36920145)
5. M Wagner C Redaelli M Lietz CA Seiler H Friess MW Buchler 2004 Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 5 586 94 15122610 10.1002/bjs.4484 1:STN:280:DC%2BD2c3it1ansA%3D%3D (Pubitemid 38624667)
6. CJ Yeo JL Cameron KD Lillemoe, et al. 1995 Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients Ann Surg 221 6 721 31 7794076 10.1097/00000658-199506000-00011 1:STN:280:DyaK2MzhsVChsg%3D%3D
7. G Garcea AR Dennison CJ Pattenden CP Neal CD Sutton DP Berry 2008 Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature J Pancreas 9 2 99 132 (Pubitemid 351611725)
8. MJ Swartz CC Hsu TM Pawlik, et al. 2010 Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas Int J Radiat Oncol Biol Phys 76 3 839 44 19647950 10.1016/j.ijrobp.2009.02.071 1:CAS:528:DC%2BC3cXhvFClt7g%3D
9. JM Herman MJ Swartz CC Hsu, et al. 2008 Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital J Clin Oncol 26 3503 3510 18640931 10.1200/JCO.2007.15.8469
10. JP Neoptolemos JA Dunn DD Stocken, et al. 2001 Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial Lancet 358 9293 1576 85 11716884 10.1016/S0140-6736(01)06651-X 1:CAS:528:DC%2BD3MXosFKmtro%3D (Pubitemid 33101907)
11. JP Neoptolemos DD Stocken H Friess, et al. 2004 A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 12 1200 10 15028824 10.1056/NEJMoa032295 1:CAS:528:DC%2BD2cXit12rtr8%3D (Pubitemid 38339364)
12. H Oettle S Post P Neuhaus, et al. 2007 Adjuvant chemotherapy with gemcitabine versus observation in patients undergoing curative-intent resection of pancreatic cancer. A randomized controlled trial JAMA 297 3 267 77 17227978 10.1001/jama.297.3.267 1:CAS:528:DC%2BD2sXotVCmug%3D%3D (Pubitemid 46143304)
13. DD Stocken MW Buchler C Dervenis, et al. 2005 Meta-analysis of randomized adjuvant therapy trials for pancreatic cancer Br J Cancer 92 8 1372 81 15812554 10.1038/sj.bjc.6602513 1:CAS:528:DC%2BD2MXjsVSjsbs%3D (Pubitemid 40705002)
14. DK Chang AL Johns ND Merrett, et al. 2009 Margin clearance and outcome in resected pancreatic cancer J Clin Oncol 27 2855 2862 19398572 10.1200/JCO.2008.20.5104
15. DE Heron RL Ferris M Karamouzis, et al. 2009 Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial Int J Radiat Oncol Biol Phys 10.1016/j.ijrobp.2008.12.075 19464819 Published on May 21, 2009
16. JC Rwigema DE Heron RL Ferris, et al. 2010 Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma-updated report of the University of Pittsburgh experience Am J Clin Oncol 33 3 286 93 19875950
17. Rwigema JC, Heron DE, Ferris RL, Andrade RS, Gibson MK, Yang Y, Ozhasoglu C, Argiris AE, Grandis JR, Burton SA. The impact of tumor volume and radiotherapy dose on outcome in previously-irradiated recurrent squamous-cell carcinoma of the head and neck treated with stereotactic body radiation therapy. Am J Clin Oncol. 2010 Oct [In Press].
18. JC Rwigema SD Parikh DE Heron M Howell H Zeh AJ Moser N Bahary A Quinn SA Burton 2010 Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas Am J Clin Oncol 33 3 286 93 19875950
19. DT Chang D Schellenberg J Shen, et al. 2009 Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas Cancer 115 665 672 19117351 10.1002/cncr.24059
20. AC Koong QT Le A Ho, et al. 2004 Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 58 1017 1021 15001240 10.1016/j.ijrobp.2003.11.004 (Pubitemid 38314781)
21. Mahadevan A, Jain S, Goldstein M, Miksad R, Pleskow D, Sawhney M, Brennan D, Callery M, Vollmer C. Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2010 Feb 18. [Epub ahead of print]
22. MK Sanders A Khalid KE Fasanella, et al. 2008 EUS-guided fiducial placement for stereotactic radiosurgery in pancreatic cancer. EUS-guided fiducial placement for stereotactic radiosurgery in pancreatic cancer Gastrointest Endosc 67 5 AB201 10.1016/j.gie.2008.03.519
23. JD Birkmeyer AE Siewers EV Finlayson, et al. 2002 Hospital volume and surgical mortality in the United States N Engl J Med 346 15 1128 37 11948273 10.1056/NEJMsa012337 (Pubitemid 34984604)
24. MW Buchler H Friess M Wagner C Kulli V Wagener K Z'graggen 2000 Pancreatic fistula after pancreatic head resection Br J Surg 87 7 883 9 10931023 10.1046/j.1365-2168.2000.01465.x 1:STN:280:DC%2BD3cvgtFymsQ%3D%3D (Pubitemid 30487690)
25. NT van Heek KF Kuhlmann RJ Scholten, et al. 2005 Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands Ann Surg 242 6 781 8 16327488 10.1097/01.sla.0000188462.00249.36 (Pubitemid 41714056)
26. AP Shah JB Strauss RA Abrams 2010 Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer Am J Clin Oncol 33 1 101 6 19636239 10.1097/COC.0b013e31819171b9 1:CAS:528: DC%2BC3cXhs1ygt7o%3D
27. JF Griffin SR Smalley W Jewell, et al. 1990 Patterns of failure after curative resection of pancreatic carcinoma Cancer 66 56 61 2354408 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6 1:STN:280:DyaK3c3otlyhtg%3D%3D (Pubitemid 20197085)
28. J Tepper G Nardi H Sutt 1976 Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy Cancer 37 1519 1524 1260670 10.1002/1097-0142(197603)37: 3<1519::AID-CNCR2820370340>3.0.CO;2-O 1:STN:280:DyaE287mt12juw%3D%3D
29. GR Varadhachary EP Tamm JL Abbruzzese, et al. 2006 Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy Ann Surg Oncol 13 8 1035 46 16865597 10.1245/ASO.2006.08.011 Epub 2006 Jul 24 (Pubitemid 44337962)
30. Gastrointestinal Tumor Study Group 1988 Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 751 755 10.1093/jnci/80.10.751
31. JP Neoptolemos DD Stocken JA Dunn J Almond HG Beger P Pederzoli, et al. 2001 Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial Ann Surg 234 758 68 11729382 10.1097/00000658- 200112000-00007 1:STN:280:DC%2BD38%2FlvFSqsg%3D%3D (Pubitemid 33117196)
32. JM Winter JL Cameron KA Campbell MA Arnold DC Chang J Coleman, et al. 2006 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience J Gastrointest Surg 10 1199 210 17114007 10.1016/j.gassur.2006.08.018 (Pubitemid 44781200)
33. TA Sohn CJ Yeo JL Cameron L Koniaris S Kaushal RA Abrams, et al. 2000 Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 567 79 11307091 10.1016/S1091- 255X(00)80105-5 1:STN:280:DC%2BD3Mzlt1yqtA%3D%3D
34. A Westgaard S Tafjord IN Farstad M Cvancarova TJ Eide O Mathisen OP Clausen IP Gladhaug 2008 Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor BMC Cancer 8 5 18194510 10.1186/1471-2407-8-5 (Pubitemid 351298389)